Yingliang Wu Selected Research

Yingliang Wu Research Topics

Disease

33	Neoplasms (Cancer) 11/2023 - 05/2010
15	Infections 01/2023 - 01/2011
9	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2016
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 06/2017
7	Virus Diseases (Viral Diseases) 11/2023 - 09/2015
7	COVID-19 01/2023 - 01/2020
6	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 02/2011
5	Lung Neoplasms (Lung Cancer) 01/2023 - 10/2019
5	Inflammation (Inflammations) 10/2021 - 11/2014
4	Neoplasm Metastasis (Metastasis) 12/2023 - 04/2014
4	Channelopathies 11/2023 - 01/2011
4	Glioma (Gliomas) 01/2023 - 05/2010
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 10/2013
3	Ataxia (Dyssynergia) 01/2021 - 10/2005
3	Bacterial Infections (Bacterial Infection) 08/2012 - 11/2008
2	Severe Fever with Thrombocytopenia Syndrome 01/2023 - 01/2020
2	Diabetic Foot 01/2022 - 08/2019
2	Lymphoma (Lymphomas) 01/2022 - 03/2018
2	Wounds and Injuries (Trauma) 01/2022 - 08/2019
2	Ulcer 01/2022 - 08/2019
2	Peritonitis 10/2021 - 01/2018
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2021 - 11/2019
2	Epilepsy (Aura) 01/2021 - 01/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2020 - 02/2015
2	Hypersensitivity (Allergy) 01/2019 - 03/2017
2	Adenocarcinoma 06/2017 - 01/2013
2	Fibrosarcoma 02/2015 - 08/2012
2	Cardiotoxicity 01/2014 - 06/2011
2	Edema (Dropsy) 12/2013 - 12/2005
1	Pain (Aches) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Post-Acute COVID-19 Syndrome 05/2022
1	Sepsis (Septicemia) 10/2021
1	Tick Bites 01/2021
1	Pruritus (Itching) 01/2021
1	Rheumatoid Arthritis 11/2020

Drug/Important Bio-Agent (IBA)

23	Peptides (Polypeptides)IBA 11/2023 - 02/2007
12	Scorpion Venoms (Scorpion Venom)IBA 11/2023 - 01/2011
6	Phosphotransferases (Kinase)IBA 01/2023 - 03/2018
6	Proteins (Proteins, Gene)FDA Link 11/2022 - 08/2011
6	VaccinesIBA 01/2022 - 01/2019
5	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2011
5	Phenol (Carbolic Acid)FDA Link 01/2022 - 03/2016
5	Anaplastic Lymphoma KinaseIBA 03/2021 - 03/2018
5	DefensinsIBA 01/2021 - 12/2017
4	Ion Channels (Ion Channel)IBA 01/2021 - 01/2011
4	fosbretabulin (combretastatin A4)IBA 12/2015 - 08/2012
3	CrizotinibIBA 12/2023 - 01/2018
3	PotassiumIBA 01/2023 - 01/2013
3	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 01/2020
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 03/2018
3	Tubulin ModulatorsIBA 01/2022 - 01/2017
3	Immune Checkpoint InhibitorsIBA 03/2021 - 08/2020
3	Potassium Channels (Potassium Channel)IBA 11/2020 - 02/2007
3	TubulinIBA 01/2020 - 02/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 11/2011
2	Therapeutic UsesIBA 11/2023 - 01/2022
2	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2023 - 11/2022
2	Chymotrypsin FDA Link 11/2022 - 04/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2022 - 08/2018
2	2- methoxy- 5- ((3,4,5- trimethosyphenyl)seleninyl)phenolIBA 01/2022 - 03/2016
2	Antimicrobial PeptidesIBA 01/2022 - 06/2016
2	B7-H1 AntigenIBA 03/2021 - 11/2020
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 05/2008
2	CytokinesIBA 01/2021 - 08/2019
2	Indicators and Reagents (Reagents)IBA 11/2020 - 08/2019
2	VenomsIBA 01/2020 - 02/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 08/2019 - 01/2019
2	Interleukin-2 (IL2)IBA 01/2019 - 02/2015
2	InterferonsIBA 12/2018 - 01/2016
2	Chloride Channels (Chloride Channel)IBA 02/2016 - 05/2010
2	ChlorotoxinIBA 02/2016 - 11/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 06/2011
2	4-methylcyclopentadecanoneIBA 01/2014 - 12/2013
2	Xylenes (Xylene)IBA 12/2013 - 12/2005
2	2- methoxy- 5- (2- (3,4,5- trimethoxyphenyl)thiophen- 3- yl)anilineIBA 01/2013 - 08/2012
1	Sirolimus (Rapamycin)FDA Link 12/2023
1	monodansylcadaverineIBA 12/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023
1	Acridine OrangeIBA 12/2023
1	TriazinesIBA 11/2022
1	ThiophenesIBA 11/2022
1	Angiotensin Receptor AntagonistsIBA 03/2022
1	ceritinibIBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2021
1	aluminum sulfate (alum)IBA 10/2021
1	CalciumIBA 01/2021
1	Salivary Proteins and PeptidesIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	capivasertibIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Kv1.2 Potassium ChannelIBA 01/2021

Therapy/Procedure

14	Therapeutics 05/2022 - 05/2010
4	Immunotherapy 01/2023 - 08/2020
2	Drug Therapy (Chemotherapy) 07/2022 - 08/2020
2	Intravenous Injections 03/2016 - 08/2012
1	Critical Care (Surgical Intensive Care) 07/2022